View in EDS HTML Full Text PDF Full Text

Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Saved in:
Bibliographic Details
Title: Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.
Authors: Hutten SJ; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Chao X; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Badoux M; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Eijkman T; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Sheinman M; Institute of Advanced Studies, Sevastopol State University, Sevastopol, Russia., de Bruijn R; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands., Herencia-Ropero A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain.; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain., Llop-Guevara A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain., Lutz C; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Wesseling J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Division of Diagnostic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam 1066CX, Netherlands., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain., van Rheenen J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Scheele CLGJ; Center for Cancer Biology, VIB, Department of Oncology, KU Leuven, Leuven 3000, Belgium., Jonkers J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.
Corporate Authors: Grand Challenge PRECISION Consortium
Source: Science translational medicine [Sci Transl Med] 2026 Mar 18; Vol. 18 (841), pp. eads9088. Date of Electronic Publication: 2026 Mar 18.
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41849582
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hutten+SJ%22">Hutten SJ</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Chao+X%22">Chao X</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Badoux+M%22">Badoux M</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Eijkman+T%22">Eijkman T</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Sheinman+M%22">Sheinman M</searchLink>; Institute of Advanced Studies, Sevastopol State University, Sevastopol, Russia.<br /><searchLink fieldCode="AU" term="%22de+Bruijn+R%22">de Bruijn R</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.<br /><searchLink fieldCode="AU" term="%22Herencia-Ropero+A%22">Herencia-Ropero A</searchLink>; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain.; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Llop-Guevara+A%22">Llop-Guevara A</searchLink>; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain.<br /><searchLink fieldCode="AU" term="%22Lutz+C%22">Lutz C</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Wesseling+J%22">Wesseling J</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Division of Diagnostic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam 1066CX, Netherlands.<br /><searchLink fieldCode="AU" term="%22Serra+V%22">Serra V</searchLink>; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain.<br /><searchLink fieldCode="AU" term="%22van+Rheenen+J%22">van Rheenen J</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Scheele+CLGJ%22">Scheele CLGJ</searchLink>; Center for Cancer Biology, VIB, Department of Oncology, KU Leuven, Leuven 3000, Belgium.<br /><searchLink fieldCode="AU" term="%22Jonkers+J%22">Jonkers J</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Grand+Challenge+PRECISION+Consortium%22">Grand Challenge PRECISION Consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2026 Mar 18; Vol. 18 (841), pp. eads9088. <i>Date of Electronic Publication: </i>2026 Mar 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41849582
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/scitranslmed.ads9088
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: eads9088
    Titles:
      – TitleFull: Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hutten SJ
      – PersonEntity:
          Name:
            NameFull: Chao X
      – PersonEntity:
          Name:
            NameFull: Badoux M
      – PersonEntity:
          Name:
            NameFull: Eijkman T
      – PersonEntity:
          Name:
            NameFull: Sheinman M
      – PersonEntity:
          Name:
            NameFull: de Bruijn R
      – PersonEntity:
          Name:
            NameFull: Herencia-Ropero A
      – PersonEntity:
          Name:
            NameFull: Llop-Guevara A
      – PersonEntity:
          Name:
            NameFull: Lutz C
      – PersonEntity:
          Name:
            NameFull: Wesseling J
      – PersonEntity:
          Name:
            NameFull: Serra V
      – PersonEntity:
          Name:
            NameFull: van Rheenen J
      – PersonEntity:
          Name:
            NameFull: Scheele CLGJ
      – PersonEntity:
          Name:
            NameFull: Jonkers J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 03
              Text: 2026 Mar 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1946-6242
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 841
          Titles:
            – TitleFull: Science translational medicine
              Type: main
ResultId 1